Advertisement
Singapore markets close in 6 hours 30 minutes

  • Straits Times Index

    3,270.60
    -22.53 (-0.68%)
     

  • Nikkei

    37,768.23
    -691.85 (-1.80%)
     

  • Hang Seng

    17,265.64
    +64.37 (+0.37%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Bitcoin USD

    64,268.30
    -2,346.05 (-3.52%)
     

  • CMC Crypto 200

    1,387.94
    -36.16 (-2.54%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Gold

    2,331.40
    -7.00 (-0.30%)
     

  • Crude Oil

    82.71
    -0.10 (-0.12%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • FTSE Bursa Malaysia

    1,571.27
    -0.21 (-0.01%)
     

  • Jakarta Composite Index

    7,157.08
    -17.45 (-0.24%)
     

  • PSE Index

    6,580.50
    +7.75 (+0.12%)
     

Endocyte (ECYT) Worth Watching: Stock Soars 17%

Zacks Equity Research

Endocyte, Inc. (ECYT) was a big mover last session with its shares rising just over 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above past one month’s volatile price range of $6.31 to $7.36.

This biopharmaceutical company has seen 2 positive estimate revisions in the last 60 days. The Zacks Consensus Estimate has also moved considerably higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s price climb can turn into more strength down the road.

Endocyte currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Investors interested in the Med-Drugs industry may also consider stocks like Mallinckrodt plc (MNK), Lannett Company, Inc. (LCI) and Endo International plc (ENDP). While Mallinckrodt and Lannett Company sport a Zacks Rank #1, Endo International bears a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




ENDOCYTE INC (ECYT): Free Stock Analysis Report

MALLINCKRODT PUBLIC LTD CO (MNK): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report

ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report


Zacks Investment Research